Precipio Inc (NASDAQ:PRPO)’s share price traded down 6.4% on Tuesday . The company traded as low as $0.43 and last traded at $0.44. 897,200 shares traded hands during mid-day trading, a decline of 28% from the average session volume of 1,249,437 shares. The stock had previously closed at $0.47.
Separately, ValuEngine raised Precipio from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd.
The company has a current ratio of 0.14, a quick ratio of 0.12 and a debt-to-equity ratio of 0.22.
A hedge fund recently bought a new stake in Precipio stock. Sabby Management LLC bought a new stake in shares of Precipio Inc (NASDAQ:PRPO) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 764,411 shares of the biotechnology company’s stock, valued at approximately $411,000. Sabby Management LLC owned about 3.88% of Precipio at the end of the most recent reporting period. Institutional investors own 11.41% of the company’s stock.
Precipio, Inc provides platform to eradicate the problem of misdiagnosis within academic institutions. The company also delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.